(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12th focused on testis cancer. In this session, the organizers convened a “Clinical Trials Corner” in which Dr. Craig Nichols presented an update on the SWOG S1823 study, a prospective observational cohort study assessing microRNA 371 for outcome prediction in patients with germ cell tumors.